Pages

Look Towards A New Future

Jul 10, 2012

Diabetic Foot Ulcer Therapeutics Market Forecasts to 2019

The report provides information on the key drivers and challenges of the Diabetic Foot Ulcers Therapeutics market. Its scope includes - 
- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Diabetic Foot Ulcers Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019. 
- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
- Analysis of the current and future competition in the seven key countries Diabetic Foot Ulcers Therapeutics market. 
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. 
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Diabetic Foot Ulcers Therapeutics market.
- Analysis of key recent licensing and partnership agreements in Diabetic Foot Ulcers Therapeutics market 

Reasons to buy

The report will enhance your decision making capability. It will allow you to - 
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline. 
- Develop business strategies by understanding the trends shaping and driving the global Diabetic Foot Ulcers Therapeutics market. 
- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Diabetic Foot Ulcers Therapeutics market in future. 
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. 
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. 
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. 
- What’s the next big thing in the global Diabetic Foot Ulcers Therapeutics market landscape? – Identify, understand and capitalize.


Buy your copy of this report @ http://www.reportsnreports.com/reports/174216-diabetic-foot-ulcer-therapeutics-pipeline-assessment-and-market-forecasts-to-2019.html

Report Details:
Published: July 2012
No. of Pages: 96
Price: Single User License – US$3995              Corporate User License – US$11985




List of Figures
Figure 1: The University of Texas - Diabetic Wound Classification System 9
Figure 2: Diabetic Foot Ulcer - Pathophysiology 14
Figure 3: Diabetic Foot Infections - Antibiotic Use According to Clinical Severity 16
Figure 4: Diabetic Foot Ulcer - Referral Pathway 17
Figure 5: Diabetic Foot Infection Therapeutics Market, Global, Revenue ($m), 2006-2011 19
Figure 6: Wound-healing Therapeutics Market, Global, Revenue ($m), 2006-2011 20
Figure 7: Diabetic Foot Infection Therapeutics Market, Global, Forecast ($m), 2011-2019 21
Figure 8: Wound-healing Therapeutics Market, Global, Forecast ($m), 2011-2019 22
Figure 9: Diabetic Foot Infection Therapeutics Market, The US, Revenue ($m), 2006-2011 23
Figure 10: Wound-healing Therapeutics Market, The US, Revenue ($m), 2006-2011 24
Figure 11: Diabetic Foot Infection Therapeutics Market, The US, Forecast ($m), 2011-2019 25
Figure 12: Wound-healing Therapeutics Market, The US, Forecast ($m), 2011-2019 26
Figure 13: Diabetic Foot Infection Therapeutics Market, France, Revenue ($m), 2006-2011 27
Figure 14: Wound-healing Therapeutics Market, France, Revenue ($m), 2006-2011 28
Figure 15: Diabetic Foot Infection Therapeutics Market, France, Forecast ($m), 2011-2019 29
Figure 16: Wound-healing Therapeutics Market, France, Forecast ($m), 2011-2019 30
Figure 17: Diabetic Foot Infection Therapeutics Market, Germany, Revenue ($m), 2006-2011 31
Figure 18: Wound-healing Therapeutics Market, Germany, Revenue ($m), 2006-2011 32
Figure 19: Diabetic Foot Infection Therapeutics Market, Germany, Forecast ($m), 2011-2019 33
Figure 20: Wound-healing Therapeutics Market, Germany, Forecast ($m), 2011-2019 34
Figure 21: Diabetic Foot Infection Therapeutics Market, Italy, Revenue ($m), 2006-2011 35
Figure 22: Wound-healing Therapeutics Market, Italy, Revenue ($m), 2006-2011 36
Figure 23: Diabetic Foot Infection Therapeutics Market, Italy, Forecast ($m), 2011-2019 37
Figure 24: Wound-healing Therapeutics Market, Italy, Forecast ($m), 2011-2019 38
Figure 25: Diabetic Foot Infection Therapeutics Market, Spain, Revenue ($m), 2006-2011 39
Figure 26: Wound-healing Therapeutics Market, Spain, Revenue ($m), 2006-2011 40
Figure 27: Diabetic Foot Infection Therapeutics Market, Spain, Forecast ($m), 2011-2019 41
Figure 28: Wound-healing Therapeutics Market, Spain, Forecast ($m), 2011-2019 42
Figure 29: Diabetic Foot Infection Therapeutics Market, The UK, Revenue ($m), 2006-2011 43
Figure 30: Wound-healing Therapeutics Market, The UK, Revenue ($m), 2006-2011 44
Figure 31: Diabetic Foot Infection Therapeutics Market, The UK, Forecast ($m), 2011-2019 45
Figure 32: Wound-healing Therapeutics Market, The UK, Forecast ($m), 2011-2019 46
Figure 33: Diabetic Foot Infection Therapeutics Market, Japan, Revenue ($m), 2006-2011 47
Figure 34: Wound-healing Therapeutics Market, Japan, Revenue ($m), 2006-2011 48
Figure 35: Diabetic Foot Infection Therapeutics Market, Japan, Forecast ($m), 2011-2019 49
Figure 36: Wound-healing Therapeutics Market, Japan, Forecast ($m), 2011-2019 50
Figure 37: Diabetic Foot Ulcer Therapeutics Market, Drivers and Barriers, 2012 52
Figure 38: Opportunity and Unmet Need in Diabetic Foot Infection Therapeutics Market, 2012 53
Figure 39: Opportunity and Unmet Need in the Diabetic Foot Ulcer Wound-healing Therapeutics Market, 2012 54
Figure 40: Strategic Competitor Assessment of the Marketed Products in Diabetic Foot Ulcer Therapeutics, 2012 56
Figure 41: Diabetic Foot Ulcer Therapeutics, Clinical Pipeline by Mechanism of Action (%), 2012 65
Figure 42: Diabetic Foot Ulcer Therapeutics, Clinical Pipeline by Phase of Development (%), 2012 66
Figure 43: Technology Trends Analytics Framework, 2012 67
Figure 44: Technology Trends Analytics Framework - Description, 2012 68
Figure 45: Diabetic Foot Ulcer Therapeutics, Global, Clinical Trials by Country, 2012 72
Figure 46: Diabetic Foot Ulcer Therapeutics, Global, Clinical Trials by Phase (%), 2012 73
Figure 47: Diabetic Foot Ulcer Therapeutics, Global, Clinical Trials by Status of Development (%), 2012 74
Figure 48: Diabetic Foot Ulcer Therapeutics, Global, Overall Sponsors (%), 2012 75
Figure 49: Diabetic Foot Ulcer Therapeutics, Global, Prominent Sponsors (%), 2012 76
Figure 50: Diabetic Foot Ulcer Therapeutics, Global, Top Companies by Phase, 2012 77
Figure 51: Diabetic Foot Ulcer Therapeutics Market, Impact Analysis, 2012 78
Figure 52: Implications for Future Market Competition in the Diabetic Foot Ulcer Therapeutics Market, 2012 79
Figure 53: Diabetic Foot Ulcer Therapeutics, Clinical Pipeline by Company, 2012 81
Figure 54: GlobalData Market Size Estimation 93
Figure 55: GlobalData Market Forecasting Model 95